← Eichor
Study identifier: NCT07426913 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Condition: Breast Cancer · Anthracycline Related Cardiotoxicity in Breast Cancer · Virtual Reality  ·  Sponsor: Virginia Commonwealth University

PhaseNA
Planned participants30
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).

This description comes directly from the study's public registry record.

Talk to the study team

Arnethea Sutton, Ph.D  ·  8048277363  ·  careslab@vcu.edu

Victoria Williams  ·  8048277363  ·  williamsv4@vcu.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Adult Outpatient PavilionRichmond, Virginia, United StatesRecruiting
Cellular Immunotherapies and Transplant DepartmentRichmond, Virginia, United StatesRecruiting
VCU Health at Stony PointRichmond, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07426913